Inventor
ITESCU SILVIU
AU37 patents
⚠️ This page may combine multiple inventors who share the name “ITESCU SILVIU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ITESCU SILVIU
12 patentsUS8894972B2Nov 25, 2014
Method for treating or preventing a pancreatic dysfunction
ITESCU SILVIU4 citations83
US9301978B2Apr 5, 2016
Method of treating graft versus host disease
ITESCU SILVIU4 citations81
US8828375B2Sep 9, 2014
Expansion of haemopoietic precursors
ITESCU SILVIU8 citations81
US8242091B2Aug 14, 2012
Treatment of tumor with dnazyme directed to peroxiredoxin
ITESCU SILVIU4 citations73
US8153113B2Apr 10, 2012
Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue
ITESCU SILVIU4 citations73
US8663652B2Mar 4, 2014
Regeneration of endogenous myocardial tissue
ITESCU SILVIU3 citations62
US8486416B2Jul 16, 2013
Use of SDF-1 to improve ischemic myocardial function
ITESCU SILVIU3 citations62
US7135302B1Nov 14, 2006
Method for predicting transplant rejection
ITESCU SILVIU4 citations62
US9415072B2Aug 16, 2016
Expansion of haemopoietic precursors
ITESCU SILVIU2 citations60
US9487756B2Nov 8, 2016
Production of reprogrammed pluripotent cells
ITESCU SILVIU0 citations52
US9387234B2Jul 12, 2016
Use of SDF-1 to improve ischemic myocardial function
ITESCU SILVIU0 citations52
US9642878B2May 9, 2017
Methods for increasing osteoblastic function
ITESCU SILVIU1 citations51
MESOBLAST INT SARL
10 patentsUS10624930B2Apr 21, 2020
Treatment of immune disorders
MESOBLAST INT SARL5 citations84
US10400218B2Sep 3, 2019
Stem cell composition
MESOBLAST INT SARL11 citations84
US11491188B2Nov 8, 2022
Prevention of progressive heart failure
MESOBLAST INT SARL3 citations69
US12257270B2Mar 25, 2025
Treatment of immune disorders
MESOBLAST INT SARL0 citations62
US11406669B2Aug 9, 2022
Treatment of immune disorders
MESOBLAST INT SARL0 citations62
US11312941B2Apr 26, 2022
Stem cell composition
MESOBLAST INT SARL0 citations62
US12303536B2May 20, 2025
Method for treating heart failure
MESOBLAST INT SARL0 citations59
US12115194B2Oct 15, 2024
Prevention of progressive heart failure
MESOBLAST INT SARL1 citations59
US11712452B2Aug 1, 2023
Method for treating heart failure
MESOBLAST INT SARL0 citations59
US12473547B2Nov 18, 2025
Use of mesenchymal lineage precursor cells or stem cells (MLPSCs) for delivery of oligonucleotides in the treatment of cancer
MESOBLAST INT SARL0 citations56
MESOBLAST INC
10 patentsUS10849932B2Dec 1, 2020
Method of treating graft versus host disease
MESOBLAST INC1 citations70
US11135249B2Oct 5, 2021
Methods for increasing osteoblastic function
MESOBLAST INC0 citations61
US9480713B2Nov 1, 2016
Method for treating diabetic renal failure or syndrome X
MESOBLAST INC1 citations61
US10105394B2Oct 23, 2018
Method of treating graft versus host disease
MESOBLAST INC1 citations60
US10688134B2Jun 23, 2020
Methods of treating or preventing respiratory conditions
MESOBLAST INC0 citations51
US10596199B2Mar 24, 2020
Methods of treating or preventing rheumatic disease
MESOBLAST INC0 citations51
US10159696B2Dec 25, 2018
Methods for treating obesity and/or metabolic syndrome
MESOBLAST INC0 citations51
US10028979B2Jul 24, 2018
Methods of treating or preventing respiratory conditions
MESOBLAST INC0 citations51
US9974812B2May 22, 2018
Methods of treating or preventing rheumatic disease
MESOBLAST INC0 citations51
US9968640B2May 15, 2018
Method for treating or preventing a pancreatic dysfunction
MESOBLAST INC0 citations51
UNIV COLUMBIA
3 patentsUS7662392B2Feb 16, 2010
Use of SDF-1 or G-CSF to improve myocardial function after ischemic injury
UNIV COLUMBIA32 citations92
US7887796B2Feb 15, 2011
Method of inhibiting collagen formation by VDUP1 inhibition
UNIV COLUMBIA12 citations84
US7662794B2Feb 16, 2010
DNA enzyme to inhibit plasminogen activator inhibitor-1
UNIV COLUMBIA0 citations42